Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26629
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCadilhac, Dominique-
dc.contributor.authorCameron, Jan-
dc.contributor.authorKilkenny, Monique F-
dc.contributor.authorAndrew, Nadine Elizabeth-
dc.contributor.authorHarris, Dawn-
dc.contributor.authorEllery, Fiona-
dc.contributor.authorThrift, Amanda G-
dc.contributor.authorPurvis, Tara-
dc.contributor.authorKneebone, Ian-
dc.contributor.authorDewey, Helen-
dc.contributor.authorDrummond, Avril-
dc.contributor.authorHackett, Maree L-
dc.contributor.authorGrimley, Rohan-
dc.contributor.authorMiddleton, Sandy-
dc.contributor.authorThijs, Vincent N-
dc.contributor.authorCloud, Geoffrey-
dc.contributor.authorCarey, Mariko L-
dc.contributor.authorButler, Ernest-
dc.contributor.authorMa, Henry-
dc.contributor.authorChurilov, Leonid-
dc.contributor.authorHankey, Graeme J-
dc.contributor.authorEnglish, Coralie Kym-
dc.contributor.authorLannin, Natasha A-
dc.date2021-05-26-
dc.date.accessioned2021-05-31T22:59:13Z-
dc.date.available2021-05-31T22:59:13Z-
dc.date.issued2021-05-26-
dc.identifier.citationInternational Journal of Stroke 2021; online first: 26 Mayen_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26629-
dc.description.abstractTo address unmet needs, electronic messages to support person-centred goal attainment and secondary prevention may avoid hospital presentations/readmissions after stroke, but evidence is limited. Compared to control participants, there will be a 10% lower proportion of intervention participants who represent to hospital (emergency/admission) within 90 days of randomisation. Multicentre, double-blind, randomised controlled trial with intention-to-treat analysis. The intervention group receives 12 weeks of personalised, goal-centred and administrative electronic messages, while the control group only receives administrative messages. The trial includes a process evaluation, assessment of treatment fidelity and an economic evaluation. Confirmed stroke (modified Rankin Score: 0-4), aged â¥18 years with internet/mobile phone access, discharged directly home from hospital. Randomisation: 1:1 computer-generated, stratified by age and baseline disability.Outcomes Assessments: Collected at 90 days and 12 months following randomisation. Primary: Hospital emergency presentations/admissions within 90 days of randomisation. Secondary outcomes include goal attainment, self-efficacy, mood, unmet needs, disability, quality-of-life, recurrent stroke/cardiovascular events/deaths at 90 days and 12 months, and death and cost-effectiveness at 12 months. To test our primary hypothesis, we estimated a sample size of 890 participants (445 per group) with 80% power and two-tailed significance threshold of α=0.05. Given uncertainty for the effect size of this novel intervention, the sample size will be adaptively re-estimated when outcomes for n=668 are obtained, with maximum sample capped at 1100. We will provide new evidence on the potential effectiveness, implementation and cost-effectiveness of a tailored eHealth intervention for survivors of stroke.en_US
dc.language.isoeng
dc.subjectClinical trialen_US
dc.subjectProtocolsen_US
dc.subjectStrokeen_US
dc.subjectehealthen_US
dc.subjecthealthcare technologyen_US
dc.subjectself-managementen_US
dc.titleEXPRESS: Protocol of a randomised controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS).en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleInternational Journal of Strokeen_US
dc.identifier.affiliationThe University of Newcastle, School of Health Science and Priority Research Centre for Stroke and Brain Injury, Callaghan, New South Wales, Australiaen_US
dc.identifier.affiliationNeurologyen_US
dc.identifier.affiliationAlfred Health, Department of Neurology, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationMonash University, Department of Clinical Neuroscience, Central Clinical School, Clayton, Victoria, Australiaen_US
dc.identifier.affiliationUniversity of Newcastle, School of Medicine and Public Health, Callaghan, New South Wales, Australiaen_US
dc.identifier.affiliationPeninsula Health, Frankston, Victoria, Australiaen_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.affiliationMonash University, Peninsula Clinical School, Central Clinical School, Clayton, Victoria, Australiaen_US
dc.identifier.affiliationMonash University, Epidemiology and Prevention Unit, Department of Medicine, School of Clinical Sciences, Clayton, Victoria, Australiaen_US
dc.identifier.affiliationUniversity of Technology Sydney, Graduate School of Health, Ultimo, New South Wales, Australiaen_US
dc.identifier.affiliationMonash University, Eastern Health Clinical School, Clayton, Victoria, Australiaen_US
dc.identifier.affiliationEastern Health, Department of Neurosciences, Box Hill, Victoria, Australiaen_US
dc.identifier.affiliationThe George Institute for Global Health, Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australiaen_US
dc.identifier.affiliationUniversity of Melbourne, Melbourne Medical School, Parkville, Victoria, Australiaen_US
dc.identifier.affiliationThe University of Western Australia, Faculty of Health and Medical Sciences, Perth, Australiaen_US
dc.identifier.affiliationMonash University, Department of Medicine, School of Clinical Sciences, Clayton, Victoria, Australiaen_US
dc.identifier.affiliationGriffith University, Sunshine Coast Clinical School, Birtinya, Queensland, Australiaen_US
dc.identifier.affiliationSt Vincent's Health Australia (Sydney), St Vincent's Hospital Melbourne, and Australian Catholic University, Nursing Research Institute, Executive Suite, Level 5 DeLacy Building, St Vincentâs Hospital , Victoria Road, Darlinghurst, New South Wales, Australiaen_US
dc.identifier.affiliationUniversity of Nottingham, Faculty of Medicine and Health Sciences, Nottingham, Nottingham, United Kingdom of Great Britain and Northern Ireland..en_US
dc.identifier.doi10.1177/17474930211022678en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-8162-682Xen_US
dc.identifier.orcid0000-0002-3375-287Xen_US
dc.identifier.orcid0000-0002-4846-2840en_US
dc.identifier.orcid0000-0002-1410-4332en_US
dc.identifier.orcid0000-0001-8533-4170en_US
dc.identifier.orcid0000-0003-1211-9087en_US
dc.identifier.orcid0000-0002-7006-6908en_US
dc.identifier.orcid0000-0002-7201-4394en_US
dc.identifier.orcid0000-0002-6044-7328en_US
dc.identifier.orcid0000-0001-5910-7927en_US
dc.identifier.orcid0000-0002-2066-8345en_US
dc.identifier.pubmedid34037468
local.name.researcherChurilov, Leonid
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptNeurology-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.